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1. Introduction 
Sphingomyelinase is the only mammalian enzyme 
known to hydrolyse sphingomyelin. Hence, the 
inherited deficiency of this enzyme in Niemann-Pick 
disease results in the characteristic sphingomyelin 
lipidosis. The disease is, however, expressed in at 
least five different phenotypes [l] of which only 
types A and B lack sphingomyelinase activity. In 
types C, D and E where the lipidosis is less severe,‘ 
as also is the course of the disease, normal enzyme 
activities have been measured. Recently, however, 
Callahan et al. [2-41 have demonstrated multiple 
forms of sphingomyelinase following isoelectric 
focusing of extracts of brain, liver and cultured skin 
fibroblasts. Of particular interest was their finding 
that a specific sphingomyelinase component was 
absent in Niemann-Pick diseases types C and E. 
In view of the importance of this finding, the 
present work is reported in order to extend these 
observations on the behaviour of fibroblast sphingo- 
myelinase during isoelectric focusing. The results 
suggest hat in the original study the enzyme was 
probably in a bound state but when solubilized with 
Triton X-l 00, it moves to a much higher p1 
2. Materials and methods 
[(Methyl-r4C)choline] sphingomyelin was obtained 
from New England Nuclear Gmbh (Germany), 
ampholine from LKB-Produkter AB (Sweden), sodium 
cholate from Sigma Chemical Co. Ltd. (USA) and 
purified Triton X- 100, bovine sphingomyelin and 
4-methylumbelliferyl2-acetamido-2-deoxy-P-D-gluco- 
pyranoside from Koch Light Labs. (UK). 
North-Holland Publishing Company -Amsterdam 
2.1. czlltured skin fibroblasts 
Skin fibroblasts were grown and harvested as 
described [5]. The cell pellet was lyophilised and 
extracted into 1% (w/v) glycine [4] and the 
31 500 X g 30 min supernatant (l-2 mg protein) 
used for electrofocusing and enzyme analysis. All 
cultures were judged to be free of mycoplasma 
contamination. 
2.2. Enzyme assay 
Sphingomyelinase activity was measured as 
described [6] . The assay mixture contained, in a final 
volume of 0.2 ml, enzyme extract (50 ~1 or 100 HI), 
250 pg sodium cholate, 62 nmol [“Cl sphingomyelin 
(50 000 cpm) and 20 pmol acetate buffer, pH 5.0. 
Incubation (3 h at 37°C) was stopped by the addition 
of cold water (0.9 ml), 10% (w/v) bovine serum 
albumen (0.1 ml) and 50% (w/v) trichloroacetic acid 
(0.2 ml). The precipitate was washed once with 10% 
(w/v) trichloroacetic acid (1 ml) and the released 
[‘“Cl phosphorylcholine in the pooled supernatants 
(1 ml) was counted in Bray’s scintillation mixture. 
In the absence of added enzyme, the blank was 
50-60 cpm. 
Hexosaminidase activity was determined as 
described [7] and protein measured by the Lowry 
method [8]. 
2.3. Isoelectric focusing 
Electrofocusing was performed in J-tubes of 10 ml 
working capacity [7] but in the presence or absence 
of 0.1% (v/v) Triton X-100, as indicated. On comple- 
tion of a run (18 h at 400 V and 4°C) fractions 
(10 drops with Triton and 4 drops without Triton) 
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were collected and analysed for pH (at 4°C) and 
enzyme activity. 
2.4. Acid precipitation 
The glycine extracted supernatant was added to an 
equal volume of 0.4 M acetate buffer, pH 5.0, (assay 
buffer) in the presence or absence of 0.1% (v/v) 
Triton X-100. After 30 min at 4”C, each was centri- 
fuged at 1000 X g 10 min, the supernatant was 
retained and the pellet reconstituted in its original 
volume of appropriate buffered solution. Sphingo- 
myelinase activity was determined in all fractions, and 
in those not containing Triton X-100, additions were 
made to maintain a constant concentration in all 
assays. 
3. Results and discussion 
When run in the absence of Triton X-100, the 
isoelectric focusing profile of fibroblast sphingo- 
myelinase was (fig. 1 a) closely similar to that reported 
by Callahan and Khalil [4]. The major enzyme peak 
was at about pH 5.0, with a pI between 4.95.and 
5.20 on two separate occasions, there was a shoulder 
of activity at ~18.1. There was evidence of two 
sphingomyelinase components in the major peak, 
the second form (~15.2) possibly being the compo- 
nent whose deficiency has been associated [3,4] 
with Niemann-Pick diseases types C and E. Shown 
also in fig. 1 a, as a reference enzyme, is the profile of 
fibroblast hexosaminidase activity. The two charac- 
teristic peaks of hexosaminidase A (~15.2) and 
hexosaminidase B (~18.5) are seen. The p1 of hexos- 
aminidase B is somewhat higher than that reported 
earlier [9] and would appear to be due to the presence 
of glycine, also some loss of hexosaminidase B 
activity is evident following its sedimentation at 
31 500 X g for 30 min. 
The sphingomyelinase assay unfortunately 
necessitated l-2 mg protein to be loaded on the 
column which resulted in a considerable band of 
precipitated protein in the region of the major 
sphingomyelinase peak. In order to alleviate this 
problem, Triton X-l 00 was included in subsequent 
focusing experiments. Under these conditions it was 
found (fig.lc) that the major band of sphingo- 
myelinase then focused at ~19.0. (between ~18.75 
and 9.10, on two occasions). On the acid side of 
this peak a number of other components were 
evident, at pI values of 8.3,7.8, a broad band 
between ~17.0-6.3 and one at pI 5.1. The enzyme 
peak could be demonstrated using either [ 14C] sphingo- 
myelin or [3H] dihydrosphingomyelin [4] as substrate 
so- 
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Fig.1. Isoelectric focusing profiles of fibroblast sphingo- 
myelinase (0) and hexosaminidase (o) activities. (a) Focusing 
performed in the absence of Triton X-100 as described in the 
text. Supernatant contained 1.50 mg protein, sphingo- 
myelinase activity 71.5 nmol/h/mg protein (representing 75% 
extraction from the total homogenate). (b) Fractions between 
$4.3 and 6.1 on fig.1 (a) refocused but in the presence of 
0.1% (v/v) Triton X-100. (c) Focusing performed in the 
presence of 0.1% (v/v) Triton X-100. Supernatant contained 
1.96 mg protein, sphingomyelmase activity 46.7 nmol/h/mg 
protein (60% enzyme extraction). 
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and enzyme recovery from the column was estimated 
to be about 80% of that applied. Under these condi- 
tions, however, the hexosaminidase profile was 
unchanged. 
In order to demonstrate that this apparent change 
in sphingomyelinase pZ was brought about by the 
presence of Triton X-100, fractions between pH 4.3 
and 6.1 from the first column (fig.la) were pooled 
and refocused in the presence of Triton X-100. The 
enzyme now focused with its major peak at pZ 
8.6-8.8 (fig.lb) with a shoulder of other components 
on its acid side, closely resembling that profile seen 
in fig.lc. 
Since the pZ of bound sphingomyelinase corre- 
sponds to that of its activity pH optimum [4,10] it 
would seem likely that during enzyme assay, in the 
absence of Triton X-100, considerable precipitation 
might occur, resulting in apparent loss of sphingo- 
myelinase activity. For example, when assayed in the 
presence of 0.025% (v/v) Triton X-100, sphingo- 
myelinase activities of the supernatant fraction and its 
pellet were 432 and 232 nmol/h/ml, whereas in the 
absence of the detergent, activities were reduced by 
some 85% to 62 and 40 nmol/h/ml. It can be seen that 
sphingomyelinase xtraction into glycine was generally 
poor (60-75%) however, extraction into sodium 
cholate [lo] gave recoveries of 93-96%. Addition of 
Triton X-100 to this extract improved little (10%) its 
sphingomyelinase activity, and its focusing profile was 
similar to that shown in fig.lc. Shown in table 1 is the 
effect of Triton X-100 in preventing enzyme precipita- 
tion by acetate buffer, pH 5.0. Virtually no enzyme 
was precipitated in the presence of Triton X-100 
whereas in its absence 30% of the sphingomyelinase 
was lost to the sediment. 
The foregoing results indicate that sphingomyelin- 
ase normally exists in a bound state but that it can be 
freed by the presence of Triton X-100. However, the 
exact nature of the material to which it is bound is 
not known. Gatt and Gottesdiner [l l] have speculated 
that in rat brain the enzyme exists as a multienzyme 
aggregate of about 300 000 daltons and that in the 
presence of Triton X-100 this was reduced to 
200 000 daltons. Furthermore, cellular distribution 
studies [ 121 have indicated that sphingomyelinase 
activity may not be found exclusively in the lysosomes. 
Whether such a situation is responsible for the 
existence of its various component forms must 
remain to be seen. 
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